Scilex Holding (SCLXW) Other Non-Current Liabilities (2020 - 2026)

Scilex Holding (SCLXW) recorded quarterly Other Non-Current Liabilities of $25.5 million in Q1 2026, up 14578.74% quarter-over-quarter from $174000.0 in Q4 2025, and down 53.38% on a YoY basis from $54.8 million in Q1 2025.

Scilex Holding (SCLXW) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends

Scilex Holding's Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $25.5 million for Q1 2026.

  • In Q1 2026, Other Non-Current Liabilities fell 53.38% year-over-year to $25.5 million; the TTM figure through Mar 2026 stood at $25.5 million (down 53.38% YoY), while the FY2025 annual figure was $174000.0, down 82.6% from the prior year.
  • Other Non-Current Liabilities was $25.5 million for Q1 2026 at Scilex Holding, up from $174000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $82.0 million in Q3 2025 to a low of $76788.0 in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $11.9 million across 5 years, with a median of $1.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities tumbled 97.88% in 2022, then surged 8344.03% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $1.2 million in 2022, then gained by 23.31% to $1.5 million in 2023, then slumped by 34.12% to $1.0 million in 2024, then slumped by 82.6% to $174000.0 in 2025, then jumped by 14578.74% to $25.5 million in 2026.
  • The last three Other Non-Current Liabilities figures came in at $25.5 million (Q1 2026), $174000.0 (Q4 2025), and $82.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Scilex Holding - - 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.54 Mn
Dec 31, 2025 174,000.00
Sep 30, 2025 81.98 Mn
Jun 30, 2025 165,000.00
Mar 31, 2025 54.79 Mn
Dec 31, 2024 1.00 Mn
Sep 30, 2024 11.45 Mn
Jun 30, 2024 187,000.00
Mar 31, 2024 6.94 Mn
Dec 31, 2023 1.52 Mn
Sep 30, 2023 2.10 Mn
Jun 30, 2023 6.57 Mn
Mar 31, 2023 6.48 Mn
Dec 31, 2022 1.23 Mn
Sep 30, 2022 1.16 Mn
Jun 30, 2022 1.23 Mn
Mar 31, 2022 76,788.00
Dec 31, 2021 35.70 Mn
Sep 30, 2021 4.86 Mn
Jun 30, 2021 3.69 Mn